CAS 831234-13-0

Fórmula: C19H17N3O

InChI: InChI=1S/C19H17N3O/c1-2-7-15(8-3-1)14-22-18-11-5-4-10-17(18)21-19(22)20-13-16-9-6-12-23-16/h1-12H,13-14H2,(H,20,21)

Clave InChI: OECUWHDVQIITIS-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)CN2C3=CC=CC=C3N=C2NCC4=CC=CO4

AC1903

CAS: 831234-13-0

AC1903

Fórmula: C₁₉H₁₇N₃O

Pureza: ≥98%

Peso molecular: 303.36

Ref: 54-BUP06675

N-(2-Furanylmethyl)-1-(Phenylmethyl)-1H-Benzimidazol-2-Amine

CAS: 831234-13-0

N-(2-Furanylmethyl)-1-(Phenylmethyl)-1H-Benzimidazol-2-Amine

Fórmula: C₁₉H₁₇N₃O

Pureza: 99%

Peso molecular: 303.36

Ref: 54-OR1023739

AC1903

CAS: 831234-13-0

1-Benzyl-N-[(furan-2-yl)methyl]-1H-1,3-benzodiazol-2-amine

Fórmula: C₁₉H₁₇N₃O

Pureza: 99%

Peso molecular: 303.36

Ref: IN-DG00996203

AC1903

CAS: 831234-13-0

AC1903 is a specific inhibitor of TRPC5 channel, and has been shown to suppress severe proteinuria and prevent podocyte loss.

Fórmula: C₁₉H₁₇N₃O

Pureza: 98.45%

Forma y color: White Solid

Peso molecular: 303.3578

Ref: TM-T8528

1-benzyl-N-[(furan-2-yl)methyl]-1H-1,3-benzodiazol-2-amine

CAS: 831234-13-0

Pureza: 99%

Peso molecular: 303.3649902

Ref: 10-F864158

AC1903

CAS: 831234-13-0

AC1903 is a growth factor that has been shown to increase the glomerular filtration rate in wild-type mice. The effective dose of AC1903 is 1.25mg/kg, which was determined by testing the effects on human osteosarcoma cells and measuring the uptake of Ca2+. AC1903 has also been shown to reduce tumor growth and metastasis in cancer cells by inhibiting epidermal growth factor (EGF) and VEGF pathways. It does this by binding to the cation channel, inhibiting calcium overload, and reducing cellular uptake of cations.

Fórmula: C₁₉H₁₇N₃O

Pureza: Min. 95%

Peso molecular: 303.36 g/mol

Ref: 3D-GIB23413

1-Benzyl-N-[(furan-2-yl)methyl]-1H-1,3-benzodiazol-2-amine

CAS: 831234-13-0

Fórmula: C₁₉H₁₇N₃O

Pureza: 98%

Forma y color: Solid

Peso molecular: 303.3578

Ref: IN-DA01DWP0